Copyright: ©Author(s) 2026.
World J Gastrointest Pharmacol Ther. Jun 5, 2026; 17(2): 116608
Published online Jun 5, 2026. doi: 10.4292/wjgpt.v17.i2.116608
Published online Jun 5, 2026. doi: 10.4292/wjgpt.v17.i2.116608
Figure 1 Main phases of inflammatory bowel disease development and typical therapy outcomes.
IBD: Inflammatory bowel disease.
Figure 2 The existing range of approaches to inflammatory bowel disease severity monitoring (the key modalities used in active inflammatory bowel disease are framed).
POC: Point-of-care; IBD: Inflammatory bowel disease; HRQoL: Health-related quality of life; CT: Computed tomography; MR: Magnetic resonance.
- Citation: Loktionov A. Current approaches to disease severity and therapy effectiveness assessment in patients with inflammatory bowel disease. World J Gastrointest Pharmacol Ther 2026; 17(2): 116608
- URL: https://www.wjgnet.com/2150-5349/full/v17/i2/116608.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v17.i2.116608